Alex Day
Contact Info
Office Hours
- Today
- -
Alex Day
About Alex Day
Alex Day is a leading consultant eye surgeon at Moorfields Private Eye Hospital, London. His areas of clinical expertise include LASIK, transPRK and SMILE laser vision correction, and lens surgery including refractive lens exchange (RLE) and cataract surgery with extended depth of focus and multifocal intraocular lens implants, and EVO implantable collamer lens (ICL, implantable contact lens). Mr Alex Day is an honorary Associate Professor at University College London (UCL) and has published over 80 peer-reviewed papers, his main research area being refractive and cataract surgery.
Mr Day qualified as a doctor from St George's Hospital Medical School, London, with a double Distinction and 1st Class BSc (Hons). His Ophthalmology training was initially on the south London rotation, moving to Moorfields Eye Hospital in 2007 and undergoing 10 years of additional training. During his Higher Surgical Training at Moorfields, he worked as a Specialist Registrar whilst completing his PhD at University College London, later becoming an NIHR Academic Clinical Lecturer and Fellow. Mr Day undertook fellowship subspecialist training in Cataract, Glaucoma and Corneal transplant surgery at Moorfields Eye Hospital, while also worked as a part time refractive surgery fellow to Mr Julian Stevens, as a full time refractive surgery fellow and as a Consultant Ophthalmic Surgeon specialising in LASIK, SMILE and cataract surgery at the London Vision Clinic.
Mr Day is on the UK General Medical Council (GMC) Specialist Register, became a Member of the Royal College of Ophthalmologists (MRCOphth) in 2007 and later a Fellow of the Royal College of Ophthalmologists (FRCOphth) in 2013. He also holds the Royal College of Ophthalmologists DRCOphth, Royal College of Ophthalmologists Certificate in Laser and Refractive Surgery (CertLRS) and the Ulster University Postgraduate Diploma in Cataract and Refractive Surgery (PGDip CRS, Distinction). He is an examiner for the Royal College of Ophthalmologists' CertLRS examination.
Mr Alex Day's clinic is at Moorfields Eye Hospital, a world renowned centre of excellence for eye surgery. Mr Alex Day is recognised internationally as an specialist in all areas of refractive surgery including laser eye surgery, EVO ICL and other lens surgery including cataract surgery and refractive lens exchange with premium intraocular lenses.
Select Your Region
Latin America
References
1. Packer M. The Implantable Collamer Lens with a central port: review of the literature. Clin Ophthalmol. 2018;12:2427-2438.
2. Martínez-Plaza E, López-Miguel A, López-De La Rosa A, et al. Effect of the EVO+ Visian Phakic Implantable Collamer Lens on Visual Performance and Quality of Vision and Life, Am J Ophthalmol 2021;226: 117-125.
3. Packer M. Evaluation of the EVO/EVO+ Sphere and Toric Visian ICL: Six Month Results from the United States Food and Drug Administration Clinical Trial. Clin Ophthalmol. 2022;16:1541-53.
4. Parkhurst GD. A prospective comparison of phakic collamer lenses and wavefront-optimized laser-assisted in situ keratomileusis for correction of myopia. Clin Ophthalmol. 2016;10:1209-1215.
5. Zhang H, Deng Y, Ma K, Yin H, Tang J. Analysis on the changes of objective indicators of dry eye after implantable collamer lens (ICL) implantation surgery. Graefes Arch Clin Exp Ophthalmol. 2024 Jul;262(7):2321-2328.
6. Albo C, Nasser T, Szynkarski DT, Nguyen N, Mueller B, Libfraind L, Parkhurst G. A Comprehensive Retrospective Analysis of EVO/EVO+ Implantable Collamer Lens: Evaluating Refractive Outcomes in the Largest Single Center Study of ICL Patients in the United States. Clin Ophthalmol. 2024 Jan 9;18:69-78.
Important Safety Information
The ICL is designed for the correction/reduction of myopia in patients, 21 to 60 years of age, ranging from -0.5 D to -20.0 D with or without astigmatism up to 6.0 D and the correction/reduction of hyperopia in patients, from 21 to 45 years of age, with hyperopia ranging from +0.5 D to +16.0 D with or without astigmatism up to 6.0 D. In order to be sure that your surgeon will use a ICL with the most adequate power for your eye, your nearsightedness, farsightedness and astigmatism should be stable for at least a year before undergoing eye surgery. ICL surgery may improve your vision without eyeglasses or contact lenses. ICL surgery does not eliminate the need for reading glasses, even if you have never worn them before. ICL represents an alternative to other refractive surgeries including, laser assisted in situ keratomileusis (LASIK), photorefractive keratectomy (PRK), incisional surgeries, or other means to correct your vision such as contact lenses and eye glasses. Implantation of an ICL is a surgical procedure, and as such, carries potentially serious risks. The following represent potential complications/adverse reactions reported in conjunction with refractive surgery in general: additional surgeries, cataract formation, loss of best corrected vision, raised pressure inside the eye, loss of cells on the innermost surface of the cornea, conjunctival irritation, acute corneal swelling, persistent corneal swelling, endophthalmitis (total eye infection), significant glare and/or halos around lights, hyphaema (blood in the eye), hypopyon (pus in the eye), eye infection, ICL dislocation, macular oedema, non-reactive pupil, pupillary block glaucoma, severe inflammation of the eye, iritis, uveitis, vitreous loss and corneal transplant. Before considering ICL surgery you should have a complete eye examination and talk with your eye care professional about ICL surgery, especially the potential benefits, risks, and complications. You should discuss the time needed for healing after surgery.